We are live on ! Find out more
LG

Laidlaw Group Portfolio holdings

AUM $210M
1-Year Est. Return 6.2%
This Fund
S&P 500
This Quarter Est. Return
+0.83%
1 Year Est. Return
+6.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$201M
AUM Growth
+$103K
Cap. Flow
-$502K
Cap. Flow %
-0.25%
Top 10 Hldgs %
36.94%
Holding
82
New
Increased
17
Reduced
38
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 15.02%
2 Industrials 9.04%
3 Financials 7.9%
4 Consumer Staples 7.39%
5 Energy 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPS icon
76
Synopsys
SNPS
$74.5B
$213K 0.11%
5,355
CB
77
DELISTED
CHUBB CORPORATION
CB
$209K 0.1%
2,300
AXP icon
78
American Express
AXP
$229B
$208K 0.1%
2,371
-400
-14% -$36K
SM icon
79
SM Energy
SM
$7.26B
$202K 0.1%
2,595
UG icon
80
United-Guardian
UG
$37.7M
$201K 0.1%
8,999
LF
81
DELISTED
LEAPFROG ENTERPRISES INC.
LF
$124K 0.06%
20,740
ANIK icon
82
Anika Therapeutics
ANIK
$200M
-5,040
Closed -$234K

Similar funds

Laidlaw Group's Q3 2014 Portfolio in Review

As of Q3 2014, Laidlaw Group held 82 positions worth $201M, up 0.05% from $201M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 1.2%. Laidlaw Group opened no new positions and exited 1, leaving the 82-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Financials.

  • Laidlaw Group added most to State Street SPDR Portfolio Short Term Corporate Bond ETF in Q3 2014, an estimated $377K increase.
  • Laidlaw Group's biggest Q3 2014 reduction was Emerson Electric, cutting an estimated $224K.
  • Laidlaw Group fully exited Anika Therapeutics in Q3 2014, selling an estimated $234K.
  • Laidlaw Group's ten largest holdings make up 37% of its $201M portfolio in Q3 2014.
  • Laidlaw Group opened 0 new positions and closed 1 in Q3 2014.
  • Laidlaw Group's portfolio value rose 0.05% quarter-over-quarter to $201M.

Based on Laidlaw Group's 13F filing for Q3 2014, filed 10 Nov 2014.